Molecular Partners AG (MOLN) Earnings Date & Reports
Molecular Partners AG is a clinical stage biopharmaceutical company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MOLN is expected to report earnings to rise 89.35% to -65 cents per share on October 27
Q3'22
Est.
$-0.66
Q4'24
Beat
by $0.31
Q3'24
Beat
by $0.07
Q4'22
Beat
by $4.20
Q2'22
Beat
by $5.25
The last earnings report on March 06 showed earnings per share of -34 cents, beating the estimate of -65 cents. With 300.00 shares outstanding, the current market capitalization sits at 130.37M.